J. Schafer

发表

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.

G. Bakris, A. Kroon, P. D. de Leeuw, 2011, Journal of the American College of Cardiology.

Placebo-Controlled Rheos Pivotal Trial Resistant Hypertension: Results From the Double-Blind, Randomized, Baroreflex Activation Therapy Lowers Blood Pressure in Patients With

G. Bakris, D. Sica, J. Bisognano, 2011 .

Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy: A Randomized Trial Comparing Simultaneous Biventricular Pacing, Sequential Biventricular Pacing, and Left Ventricular Pacing

E. Foster, Uday N. Kumar, J. Schafer, 2007, Circulation.

Effects of Long-Term Biventricular Stimulation for Resynchronization on Echocardiographic Measures of Remodeling

E. Foster, Uday N. Kumar, K. Chatterjee, 2002, Circulation.

Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.

R. Wachter, A. Ducharme, M. Senni, 2016, Seminars in thoracic and cardiovascular surgery.

Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.

R. Wachter, A. Ducharme, M. Senni, 2018, International journal of cardiology.

Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy.

G. Marcus, E. Foster, L. Saxon, 2005, Journal of the American College of Cardiology.

Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

G. Bakris, H. Haller, J. Bisognano, 2012, Journal of the American Society of Hypertension : JASH.

An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.

Peter W de Leeuw, R. Wachter, G. Bakris, 2017, Journal of the American Society of Hypertension : JASH.

Chronic baroreflex activation by the Rheos® system: An overview of results from european and North American feasibility studies

E. Lovett, J. Schafer, C. Kaufman, 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy

R. Wachter, A. Ducharme, M. Senni, 2015, European journal of heart failure.

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.

R. Wachter, A. Ducharme, M. Senni, 2015, JACC. Heart failure.

Barore flex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction

R. Wachter, A. Ducharme, M. Senni, 2015 .

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.

R. Wachter, A. Ducharme, M. Senni, 2015, JACC. Heart failure.

Reduced Ventricular Volumes and Improved Systolic Function With Cardiac Resynchronization Therapy: A Randomized Trial Comparing Simultaneous Biventricular Pacing, Sequential Biventricular Pacing, and Left Ventricular Pacing

E. Foster, J. Schafer, D. D. De Lurgio, 2007, Circulation.